Related Experiment Videos
[Methods of gene therapy for inner ear diseases]
Shengli Li1, Hongliang Zhu, Xiaoxia Wang
1Department of Hearing and Acoustics, the Second Hospital, Xi'an Jiaotong University, Xi'an 710004.
Lin Chuang Er Bi Yan Hou Ke Za Zhi = Journal of Clinical Otorhinolaryngology
|November 2, 2004
Summary
Gene transfer to the inner ear was studied using three methods. Cerebrospinal fluid delivery proved safest, avoiding hair cell injury and preserving auditory function, unlike round window or cochlear basal turn methods.
Area of Science:
- Otolaryngology
- Gene Therapy
- Neuroscience
Context:
- Inner ear gene transfer is crucial for treating hearing loss and other auditory disorders.
- Evaluating different delivery routes is essential for optimizing safety and efficacy.
- Adenoviral vectors (Ad-GFP) are commonly used for gene delivery in preclinical models.
Purpose:
- To compare the safety and effectiveness of three gene transfer methods into the inner ear: round window, basal turn of cochlea, and cerebrospinal fluid.
- To assess the impact of each method on inner ear structures, hair cell integrity, and auditory function.
Summary:
- Adenoviral GFP (Ad-GFP) was delivered to guinea pig inner ears via three routes.
- All methods achieved transfection and expression in cochlear tissues, peaking on day three.
- Round window and basal turn methods caused bleeding and hair cell injury, affecting distortion product otoacoustic emissions (DPOAE).
- Cerebrospinal fluid delivery was safe, causing no hair cell damage or DPOAE changes.
Impact:
- Cerebrospinal fluid delivery represents a safe and effective strategy for inner ear gene transfer.
- Findings guide the selection of optimal gene delivery methods to preserve cochlear function.
- This research contributes to developing novel therapies for inner ear diseases.